drugset / Trial / NCT06508775

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775

Recruiting 40 enrolled Miltenyi Biomedicine GmbH
NaSingle-groupOpen-labelOther

Summary

The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.

Timeline

Start
2024-05-05
Primary completion
2040-12-31
Completion
2040-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject MB-CART20.1 Cell therapy
Subject MB-CART2019.1 Cell therapy
Subject anti-CD19 CAR-T cells Cell therapy